169 related articles for article (PubMed ID: 20579378)
1. EGFR isoforms and gene regulation in human endometrial cancer cells.
Albitar L; Pickett G; Morgan M; Wilken JA; Maihle NJ; Leslie KK
Mol Cancer; 2010 Jun; 9():166. PubMed ID: 20579378
[TBL] [Abstract][Full Text] [Related]
2. Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumors.
Albitar L; Laidler LL; Abdallah R; Leslie KK
Mol Cancer Ther; 2005 Dec; 4(12):1891-9. PubMed ID: 16373704
[TBL] [Abstract][Full Text] [Related]
3. Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cells.
Albitar L; Pickett G; Morgan M; Davies S; Leslie KK
Gynecol Oncol; 2007 Jul; 106(1):52-64. PubMed ID: 17490735
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Ras modulates epidermal growth factor responsiveness in endometrial carcinomas.
Kato K; Ueoka Y; Kato K; Tamura T; Nishida J; Wake N
Eur J Cancer; 1998 Apr; 34(5):737-44. PubMed ID: 9713283
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
Xu Y; Tong J; Ai Z; Wang J; Teng Y
J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
Gründker C; Völker P; Emons G
Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
[TBL] [Abstract][Full Text] [Related]
7. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.
Nishimura T; Nakamura K; Yamashita S; Ikeda S; Kigure K; Minegishi T
BMC Cancer; 2015 Dec; 15():957. PubMed ID: 26673416
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2.
Davies S; Dai D; Feldman I; Pickett G; Leslie KK
Gynecol Oncol; 2004 Aug; 94(2):463-70. PubMed ID: 15297189
[TBL] [Abstract][Full Text] [Related]
9. A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model.
Liu Z; Wan G; Heaphy C; Bisoffi M; Griffith JK; Hu CA
Mol Cell Biochem; 2007 Mar; 297(1-2):179-87. PubMed ID: 17119852
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line.
Darnel AD; Archer TK; Yang K
J Steroid Biochem Mol Biol; 1999; 70(4-6):203-10. PubMed ID: 10622409
[TBL] [Abstract][Full Text] [Related]
11. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
Lynch TJ; Bell DW; Sordella R; Gurubhagavatula S; Okimoto RA; Brannigan BW; Harris PL; Haserlat SM; Supko JG; Haluska FG; Louis DN; Christiani DC; Settleman J; Haber DA
N Engl J Med; 2004 May; 350(21):2129-39. PubMed ID: 15118073
[TBL] [Abstract][Full Text] [Related]
12. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.
Cragg MS; Kuroda J; Puthalakath H; Huang DC; Strasser A
PLoS Med; 2007 Oct; 4(10):1681-89; discussion 1690. PubMed ID: 17973573
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
[TBL] [Abstract][Full Text] [Related]
14. Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.
Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M
BMC Cancer; 2011 Jan; 11():31. PubMed ID: 21266046
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
[TBL] [Abstract][Full Text] [Related]
16. An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).
Ferrer-Soler L; Vazquez-Martin A; Brunet J; Menendez JA; De Llorens R; Colomer R
Int J Mol Med; 2007 Jul; 20(1):3-10. PubMed ID: 17549382
[TBL] [Abstract][Full Text] [Related]
17. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
Wang J; Shi H; Xie Y; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
[TBL] [Abstract][Full Text] [Related]
18. Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma.
Bean J; Riely GJ; Balak M; Marks JL; Ladanyi M; Miller VA; Pao W
Clin Cancer Res; 2008 Nov; 14(22):7519-25. PubMed ID: 19010870
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
[TBL] [Abstract][Full Text] [Related]
20. Activation of epidermal growth factor receptor results in snail protein but not mRNA overexpression in endometrial cancer.
Hipp S; Walch A; Schuster T; Losko S; Laux H; Bolton T; Höfler H; Becker KF
J Cell Mol Med; 2009 Sep; 13(9B):3858-67. PubMed ID: 19604315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
